Analysts on Wall Street project that Haemonetics (HAE) will announce quarterly earnings of $1.09 per share in its forthcoming report, representing an increase of 10.1% year over year. Revenues are projected to reach $343.02 million, increasing 7.8% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a compa ...